Age (mean ± SD), years |
49 ± 15 |
Female gender, % |
44 |
White, % |
71 |
African American, % |
7 |
American Indian, % |
7 |
Hispanic |
13 |
Family history of type 2 diabetes mellitus, % |
15 |
Hemodialysis pretransplant, % |
63 |
Peritoneal dialysis pretransplant, % |
12 |
Recipient of preemptive TX, % |
25 |
Hepatitis C seropositivity, % |
4 |
Deceased donor, % |
35 |
Pre-TX BMI > 30, % |
25 |
Pre-TX triglyceride >200 mg/dl, % |
57 |
Prednisone use at 1 month, % |
43 |
Prednisone use at 4 months, % |
48 |
Prednisone use at 12 months, % |
49 |
Tacrolimus use at 4 months, % |
93 |
Tacrolimus use at 12 months, % |
86 |
Rapamune use at 12 months, % |
6 |